Jiangsu Lianhuan Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceuticals, preparations, and active pharmaceutical ingre...
Shanghai Composite Nears Positive Territory, Pharmaceutical Stocks Surge, Computing Hardware Stocks Continue to Adjust, HSI Fluctuates Higher, New Consumption Concept Stocks Rebound, POP MART Rises 2%
The A-share innovative drug sector surged in the afternoon, with WECOME rising over 15%, Frontier Biotechnologies and SHANGHAI YIZHONG rising over 10%, and JLPC, Hongbo Pharmaceutical, Genrix Bio, and Chengda Pharmaceutical following suit
JLPC: The net profit for the third quarter was 4.9662 million yuan, a year-on-year decrease of 83.34%
JLPC: Wholly-owned subsidiary plans to purchase assets, transaction price is 74.5 million yuan
JLPC's subsidiaries sign strategic cooperation agreements
JLPC has obtained the drug registration certificate for Famotidine Injection